HHS Grants $36M in Funding for Health IT Improvement

July 25, 2016
Health and Human Services (HHS) Secretary Sylvia M. Burwell has announced more than $36 million in funding for 50 Health Center Controlled Networks (HCCNs) that will aim to greatly increase health IT support across the country.

Health and Human Services (HHS) Secretary Sylvia M. Burwell has announced more than $36 million in funding for 50 Health Center Controlled Networks (HCCNs) that will aim to greatly increase health IT support across the country.

The HCCNs will be in 41 states and Puerto Rico, though HHS says that they will impact more than 1,020 participating health center organizations in all 50 states and Puerto Rico. According to the federal agency, HCCNs improve access to care, enhance quality of care and achieve cost efficiencies through the redesign of practices to integrate services, optimize patient outcomes, or negotiate managed care contracts on behalf of participating health centers.

Specifically, the networks support health center participation in the Federal Health Information Technology Strategic Plan to: adopt and implement certified electronic health record (EHR) technology; enhance comprehensive, integrated data collection, analysis, and reporting; meet the requirements of the Medicare and Medicaid Electronic Health Records Incentive Programs; and improve clinical and operational quality, reduce health disparities, and improve population health through health information technology.

The networks promote enhanced information sharing and support health centers in achieving the requirements of the Medicare and Medicaid EHR Incentive Programs using Office of the National Coordinator for Health Information Technology (ONC)-certified EHRs, adopting technology-enabled quality improvement strategies, and engaging in health information exchange, HHS said.

Currently, nearly 1,400 health centers operate about 9,800 service delivery sites in every U.S. state, the District of Columbia, Puerto Rico, the Virgin Islands and the Pacific Basin. These health centers employ more than 170,000 staff who provide care for nearly 23 million patients. “Health Center Controlled Networks are a key tool in providing quality primary care to medically underserved communities,” Burwell said in a statement. “By using these networks, individual health centers can work together to share resources, leverage buying power, and improve access to health information technology, leading to a better care experience for vulnerable populations.”

Sponsored Recommendations

Ask the Expert: Is Your Patients' Understanding Putting You at Risk?

Effective health literacy in healthcare is essential for ensuring informed consent, reducing medical malpractice risks, and enhancing patient-provider communication. Unfortunately...

Beyond the Silos: Transforming Coordinated Care Across Healthcare Systems

Coordinated healthcare is vital to delivering a high-quality patient experience, yet it has been difficult to systematize across all healthcare settings. Although it has largely...

The Healthcare Provider's Guide to Accelerating Clinician Onboarding

Improve clinician satisfaction and productivity to enhance patient care

ASK THE EXPERT: ServiceNow’s Erin Smithouser on what C-suite healthcare executives need to know about artificial intelligence

Generative artificial intelligence, also known as GenAI, learns from vast amounts of existing data and large language models to help healthcare organizations improve hospital ...

According to an Oct. 10 press release, a report by the World Health Organization (WHO) finds that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR). While some of these vaccines are already available but underused, others would need to be developed and brought to the market as soon as possible. AMR occurs when bacteria, viruses, fungi, and parasites no longer respond to antimicrobial medicines, making people sicker and increasing the risk of illness, death and the spread of infections that are difficult to treat. AMR is driven largely by the misuse and overuse of antimicrobials, yet, at the same time, many people around the world do not have access to essential antimicrobials. Each year, nearly 5 million deaths are associated with AMR globally. Vaccines are an essential part of the response to reduce AMR as they prevent infections, reduce the use and overuse of antimicrobials, and slow the emergence and spread of drug-resistant pathogens. The new report expands on a WHO study published in BMJ Global Health last year. It estimates that vaccines already in use against pneumococcus pneumonia, Haemophilus influenzae type B (Hib, a bacteria causing pneumonia and meningitis) and typhoid could avert up to 106 000 of the deaths associated with AMR each year. An additional 543 000 deaths associated with AMR could be averted annually when new vaccines for tuberculosis (TB) and Klebsiella pneumoniae, are developed and rolled out globally. While new TB vaccines are in clinical trials, one against Klebsiella pneumoniae is in early stage of development.
dreamstime_xxl_210174616_1